Combined chemotherapy and radiofrequency electromagnetic field treatment for patients with liver dominant refractory metastatic colorectal cancer
Written informed consent prior to any study procedure
18 years or older
Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1
Histologically confirmed colorectal cancer
Significant extrahepatic metastasis
Previous treatment with TAS 102
Other concurrently active malignancies excluding malignancies that are disease free for more than 5 years or carcinoma-in-situ deemed cured by adequate treatment.
Known brain metastasis or leptomeningeal metastasis.